Restricted to GI or ID (approval w/ in 24 hours)

• • Criteria for approval (contact Legacy Specialty Pharmacy for assistance with coverage):​
    • 1st recurrence w/ risk factors (>65 yrs, immunocompromised, severe*)​
    • ≥ 2nd recurrence​
    • Vancomycin treatment failure (symptoms for >7 days on vancomycin)

• *Criteria for severe CDI - serum creatinine of >1.5 mg/dL (or ≥1.5 times baseline) or a white blood cell count of >15,000 cells/mm3, though definition of severe CDI may vary in select patients
• Note: Fidaxomicin should not be used for confirmed fulminant CDI

See Fidaxomicin Workflow & Specialty Pharmacy